Unichem Laboratories share price gained 4 percent intraday on March 16 after company received ANDA approval for its Nebivolol Tablets.
"Unichem Laboratories has received the ANDA approval for its Nebivolol Tablets 2.5mg, 5mg, 10mg, and 20mg from the US Food and Drug Administration (USFDA) to market a generic version of Bystolic (nebivolol) Tablets 2.5mg, 5mg, 10mg, and 20mg, of Allergan Sales, LLC, the company said in a press release.
Nebivolol Tablets are indicated for the treatment of hypertension. The product will be commercialised from Unichem’s Ghaziabad Plant, it added.
Catch all the market action on our live blog
At 11:16am, Unichem Laboratories was quoting at Rs 251.50, up Rs 6.05, or 2.46 percent on the BSE.
The share touched a 52-week high of Rs 374.90 and a 52-week low of Rs 197.50 on 21 May, 2021 and 22 November, 2021, respectively. It is now trading 32.92 percent below its 52-week high and 27.34 percent above its 52-week low.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
